Cancer BiologybioRxivPreprint
Developing folate-conjugated miR-34a therapeutic for prostate cancer treatment: Challenges and promises
W. Li, Y. Wang, X. Liu…·D. G. Tang
This study evaluates folate-conjugated miR-34a as a potential prostate cancer therapeutic, finding limited efficacy due to low FOLR1 expression in prostate cancer cells.
DOI 10.1101/2023.11.25.568612